Brucellar uveitis: intraocular fluids and biopsy studies  by Rolando, Isaías et al.
Brucellar uveitis: intraocular fluids and biopsy studies
Isaı´as Rolando a,b, Gustavo Vilchez b, Liset Olarte b, Marina Lluncor b,
Carlos Carrillo c, Mark Paris d,e, Humberto Guerra b, Eduardo Gotuzzo a,b,*
aHospital Nacional Cayetano Heredia, Lima, Peru
b Instituto de Medicina Tropical ‘‘Alexander von Humboldt’’, Universidad Peruana Cayetano Heredia,
Av. Honorio Delgado 430, Lima 31, Peru
cDepartment of Microbiology, Universidad Peruana Cayetano Heredia, Lima, Peru
dDepartment of Ophthalmology, A.G. Holley State Hospital, Lantana, Florida, USA
e Florida Department of Health, Tallahassee, Florida, USA
Received 9 August 2008; received in revised form 6 November 2008; accepted 5 December 2008
Corresponding Editor: Ziad Memish, Riyadh, Saudi Arabia








Background: Ocular brucellosis is usually diagnosed by clinical criteria and serological tests.
Little is known with regard to the ocular immunology of brucellosis and the use of intraocular
diagnostic tests. We report retrospectively the laboratory findings of patients with ocular
involvement associated with brucellosis.
Materials and methods: Patients with uveitis with no evident etiologic diagnosis were evaluated
at the Instituto de Medicina Tropical ‘‘Alexander von Humboldt’’ of the Universidad Peruana
Cayetano Heredia and the Hospital Nacional Cayetano Heredia. Patients were tested for
brucellosis, tuberculosis, syphilis, toxoplasmosis, toxocariasis, and human T-cell lymphotropic
virus-1. Blood and intraocular fluid samples were examined. Patients with a diagnosis of brucellar
uveitis were selected as cases and patients with a diagnosis of uveitis of other etiology were
included as controls. The Goldmann—Witmer coefficient was determined.
Results: Twelve patients with clinical and laboratory findings suggestive of brucellar uveitis were
considered as cases. Seven patients with uveitis of other etiology were selected as controls. Four
(33.3%) patients with ocular brucellosis had negative ocular agglutinations and eight (66.7%) had
positive agglutinations. No control cases had positive agglutinations for Brucella melitensis. The
sensitivity of the test was 66.7% and the specificity 100%. Only one patient had a positive culture
for B.melitensis in subretinal fluid. The Goldmann—Witmer coefficient was calculated in six cases
of brucellosis uveitis and five uveitis controls. It was highly positive in three patients with ocular
brucellosis. Tissue samples showed lymphoplasmacytic infiltrates.
Conclusions: Intraocular serological tests could be used to support the diagnosis of ocular
brucellosis.
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Brucellosis is a zoonosis caused by bacteria of the genus
Brucella. The incidence of brucellosis has decreased con-
siderably in developed countries, although it is still a public
health problem in many developing countries. As in the case
of tuberculosis and syphilis, clinical manifestations of bru-
cellosis may be varied and non-specific, involving different
systems. Although ocular presentations are rare, all the
ocular structures may be affected by brucellosis. The most
frequent ocular manifestation is uveitis, predominantly pos-
terior uveitis.1
The diagnosis of ocular brucellosis is usually made by
clinical examination and serological testing. Other infectious
etiologies may be difficult to exclude, and a diagnosis is
sometimes made by observing the response to treatment.
Nevertheless, an early and specific diagnosis is essential, as
severe complications including blindness may occur. The
current limitations of diagnostic tests make it necessary to
search for alternatives.
The aqueous humor has been studied in many ocular
inflammatory diseases.2 Most of these have demonstrated
that lymphocytes andmonocytes are the predominant cells in
patients with uveitis.2 Likewise, immunoglobulins have been
found in almost every eye structure. They are found in high
concentrations in the cornea, choroids, and conjunctiva and
in low concentrations in the ciliary body, iris, the aqueous
humor, and the retina.3
Studies have found that the uveal tissue can be sensitized
and can store memory lymphoid cells; the presence of these
cells may explain how invading organisms can induce a specific
secondary immunologic reaction. The humoral response pre-
dominates with high production of specific antibodies and T
lymphocytes for the elimination of the inducing antigen.4
The objective of this study was to report the laboratory
findings obtained from our experience of evaluating patients
with ocular involvement associated with brucellosis. The
specific antigenic responses in intraocular fluids are briefly
reviewed.
Materials and methods
From January 1980 to December 2005, cases of uveitis with
no evident etiologic diagnosis were evaluated at the Instituto
de Medicina Tropical ‘‘Alexander von Humboldt’’ of the Uni-
versidad Peruana Cayetano Heredia and the Hospital Nacio-
nal Cayetano Heredia. As part of the diagnosis process of
uveitis at our hospital, patients were tested for at least: (1)
brucellosis (agglutinations and blood/bone marrow culture),
(2) tuberculosis (purified protein derivative (PPD) and chest
X-ray), (3) syphilis (venereal disease research laboratory
(VDRL) and/or fluorescent treponemal antibody absorption
(FTA-ABS)), (4) toxoplasmosis (serum IgM for toxoplasmosis),
(5) toxocariasis (serum IgG for toxocariasis), and, in the last
six years, (6) human T-cell lymphotropic virus-1 (HTLV-1)
infection (ELISA for HTLV-1). Serum and intraocular fluids
were examined. The patients had general clinical and
ophthalmological evaluations.
From the patients with ocular involvement, the ones with
clinical evolution and/or laboratory findings suggestive of
brucellar uveitis were considered as cases, and patients withuveitis of other etiology were selected as controls. Inclusion
criteria for cases were: (1) patients with a clinical ophthal-
mological diagnosis of uveitis, and (2) positive serum agglu-
tinations for Brucella melitensis: standard agglutination (ST)
1:160, 2-mercaptoethanol (2-ME)1:80, and blocking anti-
bodies (BAB) 1:80.5 Serum agglutinations were performed
using the standard tube agglutination method; dilutions of
sera used were from 1:20 to 1:1024; the tubes were incu-
bated for 48 h at 37 8C using B. melitensis antigens. The 2-ME
test was performed in parallel with the standard tube agglu-
tination, using 2-ME at a final concentration of 0.005 M in
saline in each tube. Blocking antibody titers were deter-
mined by using a third set of tubes containing the same
dilution series; each tube received 0.1 ml of a titrated rabbit
anti-Brucella antiserum producing agglutination; inhibition
of the agglutination allowed the determination of the block-
ing antibody titer of the patient’s serum.5,6 Patients with
evidence of infection or co-infection with other pathogens
were excluded from the study.
The control cases were patients with a diagnosis of uveitis
caused by other etiologies, with negative agglutination tests
(ST, 2-ME, and BAB) for brucellosis and a clinical evolution not
compatible with ocular brucellosis.
Blood and/or bone marrow cultures were done for cases
and controls, in biphasic Ruiz-Castan˜eda bottles, and
observed for up to 60 days before being reported as negative.
Blood and intraocular fluid (aqueous and/or vitreous) sam-
ples were tested in both groups. The intraocular fluid samples
were obtained through keratocentesis or pars plana aspira-
tion using an aseptic surgical procedure.
Aqueous paracentesis was done in the operating room
using topical proparacaine. A 27-gauge needle fitted to a
1-ml disposable tuberculin syringe was introduced into the
anterior chamber. Care was taken to avoid needle contact
with blood vessels.7 Topical antibiotics were prescribed to
the patients.8 Aqueous humor samples of from 0.15 to
0.25 ml were obtained from all individuals.
Vitreous aspiration was performed through the pars plana
with a 25-gauge blunt-tipped needle following topical
anesthesia (proparacaine) under the operating microscope.8
Some patients with uveitis without etiologic diagnosis had
vitreous aspiration for cultures and/or microagglutination
tests according to the volume of the sample.
Ocular tissue samples were obtained from patients who
underwent surgery for ophthalmological indication due to
ocular complications. These tissue samples were sent for
anatomopathologic examination.
To determine the specificity of the intraocular immunoglo-
bulins, samples of aqueous or vitreous humor were analyzed
using the modified titration microtechnique described by
Gaultney et al.9 and Brown et al.10 This technique is accom-
plishedbymicroagglutinationwith a colored antigen, resulting
in the detection of antibodies for brucellosis in the IgM/IgG
classes. After treating serumwith 2-ME, agglutinating activity
of IgM is destroyed, hence, detection of IgG is possible.11
The antigen used was B. melitensis (16-M), prepared and
standardized following international guidelines.11 The work-
ing dilution of the antigen for both STand 2-ME was 1/50 with
phosphate-buffered saline (pH 7.2) with a final safranin
concentration of 0.005%. Using U-shaped rigid microtiter
plates, eight samples were processed simultaneously. The
safranin colored antigen was added, each well was stirred for
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titers were identified as pale pink cells at the bottom of a
well. In each assay, a reference serum with a known titer was
used. Any titer above zero was considered as positive for
ocular brucellosis, since no specific diagnostic titer has been
established for intraocular agglutination tests.
In addition, testing for IgG was performed on serum and
aqueoushumor,usingstandardradial immunodiffusionmethods
with a commercial Boehringer anti-IgG antiserum;mini dosage
plaques, which allow testing of small samples, were used.
Two clinical courses of brucellosis were recognized: acute,
having lasted for less than 8 weeks when seen, and subacute/
chronic, with activity for more than 8 weeks. We considered
cases with subacute and chronic brucellosis in the same group
due to the small number of patients reported. Four forms of
uveal involvement were identified: (1) anterior uveitis, (2)
posterior uveitis, (3) intermediate uveitis, and (4) panuvei-
tis.12 The intraocular inflammatory response (flare and cells),
was detected by observing the Tyndall effect in the anterior
or posterior chambers of the eye.
Data were entered into and analyzed using Microsoft Excel
spreadsheets. Variables included age, gender, systemic man-
ifestations, visual symptoms, uveitis, ocular complications,
and serological and culture results.
In order to detect the local production of specific anti-
bodies in ocular fluids, the relative antibody concentration
index value was determined (Goldmann—Witmer coefficient
or C value),13 applying the following formula:
Ocular fluid antibody titer
Total IgG in ocular fluid
:
Serum antibody titer
Total IgG in serumTable 1 Patients with brucellar uveitis and control cases
Case Sex Age Etiological diagnosis Tyndall Serum
ST 2ME
Patients with brucellosis
1 F 36 Subacute/chronic B. + 0 0
2 M 13 Subacute/chronic B. + 1280 640
3 M 22 Subacute/chronic B. + 1280 80
4 F 45 Subacute/chronic B. + 10 0
5 F 59 Subacute/chronic B. + 2560 80
6 F 60 Subacute/chronic B. + 160 0
7 F 19 Subacute/chronic B. + 640 80
8 M 28 Subacute/chronic B.  0 0
9 M 36 Subacute/chronic B.  1280 160
10 M 31 Subacute/chronic B. + 640 80
11 F 28 Subacute/chronic B.  640 0
12 F 53 Subacute/chronic B.  640 40
Patients without brucellosis (controls)
A F 58 Toxoplasmosis 10
B F 16 Tuberculosis 0
C M 46 Toxoplasmosis 0
D F 55 Tuberculosis 0
E F 53 Toxoplasmosis 0
F M 34 Pars planitis 10
G M 32 Anterior uveitis 0
ST, standard agglutination; 2ME, 2-mercaptoethanol; BAB, blocking an
coefficient; F, female; M, male; B., brucellosis; NC, not calculable.To calculate sensitivity and specificity of the microagglu-
tination test values, a 2  2 table was constructed with the
results for the cases and controls.
Results
Twelve patients with a diagnosis suggestive of brucellar
uveitis were considered as cases, and seven patients with
uveitis of other etiology were selected as controls. Of the
patients with ocular brucellosis, seven (58.3%) were women
and five (41.7%) were men. Their mean age was 35.8  15.5
years (range 13—60 years). The control group consisted of
four (57.1%) women and three (42.9%) men. Their mean age
was 42  15.3 years (range 16—58 years). Of the control
group, three patients were diagnosed with toxoplasmosis,
two with tuberculosis, one with pars planitis, and one with
anterior uveitis. The etiology of the lesions in the last two
patients was not determined (Table 1).
All patients with ocular brucellosis presented with ocular
symptoms (Table 2). Nine (75%) had at least one systemic
manifestation. The clinical course of the disease was sub-
acute/chronic (over 8 weeks) in all 12 patients.
Panuveitis was present in six (50%) patients, posterior
uveitis in two (16.7%), intermediate uveitis in three (25%),
and only one (8.3%) had anterior uveitis. All the patients had
at least one complication. Of the 12 patients, 10 (83.3%) had
cataracts, seven (58.3%) had vitreous changes, five (41.7%)
had phthisis bulbi, four (33.3%) had glaucoma, one (8.3%) had
Behc¸et’s syndrome, one (8.3%) had macular edema, one
(8.3%) had Vogt—Koyanagi—Harada syndrome, and one
(8.3%) had Harada syndrome.Intraocular Bone marrow
culture
IgG GWc
BAB ST 2ME BAB S AH
80 0 0 20 Negative 1130 15.03 18.79
0 640 — — Negative — — —
0 0 20 40 Negative 1520 35.4 10.73
80 0 0 20 Negative — — —
0 — 20 0 Positive — — —
0 0 80 0 Negative 1450 42.6 NC
0 160 80 20 Positive — — —
160 0 0 0 Negative 1730 8.3 NC
10 0 0 0 Positive 1230 8.3 NC
20 0 20 10 Negative 1680 15.03 27.94
0 0 0 0 Negative — — —
0 — 0 0 Negative — — —
0 Negative 1430 3.8 NC
0 Negative 1250 — —
0 Negative 1120 8.51 NC
0 — 930 — —
0 — 1330 3.45 NC
0 Negative 1290 9.59 NC
0 Negative 1510 3.25 NC
tibodies; S, serum; AH, aqueous humor; GWc, Goldmann—Witmer
Table 2 Clinical presentation of patients with ocular bru-
cellosis
Patient Reasons for consulting — clinical complaints
1 6 months of decreased visual acuity
2 Diagnosis of brucellosis 7 months ago;
2 months of decreased visual acuity
3 Diagnosis of brucellosis + 7 months of decreased
visual acuity, red eye and ocular pain
4 2 months of decreased visual acuity + arthralgia
5 Decreased visual acuity + 3 years of low back pain
6 Decreased visual acuity; 6 episodes of recurrent
uveitis; diagnosis of brucellosis 7 years ago
7 Red eye and decreased visual acuity
8 Red eye and decreased visual acuity + arthralgia
9 8 months of decreased visual acuity
10 Decreased visual acuity
11 8 months of decreased visual acuity
12 2 years of progressive decreased visual acuity
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with brucellar uveitis. Of these, only three (25%) were
positive for B. melitensis. Only two patients (patients 2
and 4) had blood cultures and both were negative.
Agglutination studies were performed on aqueous humor
for 11 patients and on vitreous humor for one patient. Of
these, four (33.3%) patients had negative ocular agglutina-
tions, although they were serum positive. Ocular agglutina-
tions were positive in eight (66.7%) patients. No control cases
had positive agglutinations for brucellosis (Table 1). The
sensitivity of the test was 66.7% and the specificity 100%.
Ocular fluids were cultured from eleven patients with
ocular brucellosis: three samples from vitreous humor, eight
samples from aqueous humor, and one sample from subret-
inal fluid. Both aqueous humor and subretinal fluid samples
were used for patient 5. This one patient (9.1%) had a positive
culture for B. melitensis in the subretinal fluid obtained
during retinal detachment surgery. The aqueous humor of
this patient was negative. Nine of the other ten samples
(81.8%) were negative. The remaining sample was contami-
nated. Intraocular fluids of the controls were not cultured.
The Goldmann—Witmer coefficient was calculated in six
cases of brucellar uveitis and five controls. From the group of
cases, we obtained three significant C values, the other three
were not calculable because these patients did not show
positive intraocular agglutinations, and thus the formulaTable 3 Pathological findings
Case Complications and/or sequels Tissue
3 Phthisis bulbi Ocular glob
4 Cataracts Iris
6 Cataracts Iris
7 Acute glaucoma Vitreous as




a Russell bodies, hypertrophied smooth endoplasmic reticulum of placould not be applied. None of the control patients had a
positive C value, as shown in Table 1.
Six patients with brucellar uveitis were operated on due to
ocular complications, three for cataract extraction, two for
phthisis bulbi, and one for acute glaucoma. Two control cases
(B and C) were also operated on for cataract extraction.
Tissue samples obtained during these procedures were sent
for pathological examination; results are shown in Table 3.
Discussion
Ocular infections caused by brucellosis,1 as well as other
bacterial diseases such as syphilis, tuberculosis, borreliosis,
and bartonellosis,14 are diagnosed by clinical criteria and
serological or culture tests, or through confirmation of etiol-
ogy in other organ systems.1,15 In the case of Brucella sp,
agglutination studies in several body fluids and tissues have
been undertaken.16
Ocular puncture is not routinely done as a diagnostic
procedure, and ocular inflammatory tissue biopsies are rarely
obtained,17 although these have been described as safe
procedures, even in an outpatient setting.8,17,18 One of
the main disadvantages of routine aqueous humor analysis
is the small quantity of fluid obtained, which limits the
number of tests that can be done on a single specimen.18
Only a small number of studies have been undertaken in
which ocular fluids have been used for the diagnosis of ocular
brucellosis in humans.4,19—22
The eye is one of the organs that has an immune privi-
lege,23—26 which consists of a series of physiological mechan-
isms by which immunological processes are excluded or
restricted.27 Inflammation can cause irreparable damage
to the visual axis,28,29 causing blindness in some immune-
mediated infectious diseases,30 such as herpes simplex,31
Onchocerca volvulus,32 and brucellosis.1 Humoral response
studies on infectious diseases of the eye have focused on
Toxoplasma gondii and herpes virus.33,34 Differences in the
antibodies originating in the eye and in the serum have also
been reported.23,33 The local humoral response provoked by
ocular brucellosis has not been thoroughly studied and little
is known concerning the local production of antibodies spe-
cific to Brucella species.
In this study, the threepatientswith thehighest titers (80)
were in the active phase of the disease. The titers may be
decreasedorcouldevenbecomenegative in the inactivephase
of ocular infection. This could explain the negative titers in
some patients.35 All the patients with panuveitis presentedResult
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with anterior, intermediate, or posterior uveitis alone were
more frequently negative. We cannot establish an absolute
relationship between the severity of the disease and the value
of the agglutinations. We can propose that in panuveitis, the
most severe presentation of the disease,1 the immunological
response could be more intense and destructive.
The finding of positive intraocular agglutinations in
patients with an ocular brucellosis, suggests the presence
of specific immunoglobulins in the eye. The immunoglobulins
could act individually or through immune complexes.4 It has
been stated that the deposition of immune complexes could
alter the vascular permeability of the uveal tissue in a
transitory or permanent manner, producing acute transitory
or recurrent uveitis.36 A previous study on immune complexes
has determined the specificity of the immune complexes to
Brucella antigen in three patients with brucellar uveitis,
through the Raji immunoassay technique. The control cases
were six patients with uveitis of another etiology. They had
negative tests for immune complexes to Brucella in the
aqueous humor.4
The aqueous and vitreous humors are sterile fluids, there-
fore selective media are not required for culture. However,
the small number of microorganisms in the intraocular fluid
during an infection may hamper their isolation in culture.37 It
has to be taken into consideration that Brucella sp are slow-
growing microorganisms, whose isolation can take up to 4
weeks from blood and bonemarrow samples;38 isolations may
occur in 15—70% of cultured samples.39—41 There is one prior
report on the isolation of B. melitensis in the aqueous and
vitreous humors, in a patient with endophthalmitis.19 We
report the first isolation of B. melitensis in subretinal fluid; it
was observed on the 24th day of incubation. This confirms that
the organism itself plays an important role in some cases. Two
mechanisms of ocular damage could be involved: one,
mediated by the presence of B. melitensis in the acute phase
of the disease, and the second, mediated by specific anti-
bodies and immune complexes present in the chronic phase.
In tissue biopsies, the most frequent findings were plas-
macytoid infiltrates and Russell bodies.42 This confirms the
likelihood of intraocular production of specific immunoglo-
bulins in brucellar uveitis. The biopsies of our control cases
suggest that the production of specific immunoglobulins is
also involved in infectious uveitis with other causes. These
findings are similar to those previously noted in parasitic and
viral ocular infections.43
The ocular immunology of brucellosis must be further
studied in order to allow improved characterization of the
specific ocular response to this agent. The described micro-
agglutination technique is a method that could be used to
support the diagnosis of ocular brucellosis. These results are
preliminary; studies with a larger sample size are required to
confirm our findings.
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